Stephanie Tang
Critical Care Medicine · Houston, TXNPI 1699138388
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 32 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by W. L. Gore & Associates, Inc. at 37.8% of the total. 2025 is the largest year on record at $484, 3.2 times the $152 reported in 2022.
Across 32 payments — averaging $39.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- W. L. Gore & Associates, Inc.$479
- Haemonetics Corporation$192
- Aroa Biosurgery Incorporated$151
- Solventum Corporation$56
- Kerecis Limited$51
- Medistim USA, Inc.$47
- plus $292 from 11 others
What the payments were for
- Food & beverage$1,267100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| W. L. Gore & Associates, Inc. | 10 | $479 |
| Haemonetics Corporation | 2 | $192 |
| Aroa Biosurgery Incorporated | 3 | $151 |
| Solventum Corporation | 2 | $56 |
| Kerecis Limited | 2 | $51 |
| Medistim USA, Inc. | 1 | $47 |
| Endologix LLC | 2 | $47 |
| Imperative Care, Inc | 1 | $44 |
| Baxter Healthcare | 1 | $30 |
| Surmodics, Inc. | 1 | $29 |
| KCI USA, Inc. | 1 | $28 |
| Ossur Americas, Inc. | 1 | $26 |
| Janssen Scientific Affairs, LLC | 1 | $24 |
| Convatec Inc. | 1 | $21 |
| La Jolla Pharmaceutical Company | 1 | $19 |
| Boston Scientific | 1 | $14 |
| Pfizer | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,267 in reported general payments places this provider in the 65th percentile of 507 critical care medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Acetaminophen-CodeineAcetaminophen With Codeine | 12 | $72 |
| Tramadol Hcl | 17 | $48 |
Paid to pharmacies, not to this prescriber.
Other critical care medicine in Houston
- Edwin ParsleyHouston$283K
- Bindu AkkantiHouston$185K
- Faisal MasudHouston$155K
- Sergio Trevino CastilloHouston$133K
- Sami HossriHouston$34K
- George WilliamsHouston$33K
- Nicholas VillalobosHouston$26K
- Ranjan UpadhyayHouston$25K
- Deepa GoturHouston$23K
- Hany Abd-El MalekHouston$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.